Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Umbilical Cord Blood Collection and Processing for Cardiac Regeneration in Hypoplastic Left Heart Syndrome Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by Susana Cantero Peral, M.D., Ph.D., Mayo Clinic
Information provided by (Responsible Party):
Susana Cantero Peral, M.D., Ph.D., Mayo Clinic Identifier:
First received: May 14, 2013
Last updated: August 5, 2016
Last verified: August 2016

Cell-based cardiac regeneration has been the focus of acquired, adult heart disease for many years. However, congenital heart disease with severe structural abnormalities may also be reasonable targets for cell-based therapies. Interestingly, the pediatric heart is naturally growing and may be the most amendable to regenerative strategies. Therefore, identifying autologous cells (cells from the patient's own body) would be important to initiate these studies.

This study aims to validate the use of umbilical cord blood as a source of autologous cells for the purpose of cardiac repair of congenital heart disease. Cells will be isolated from the cord blood to help us determine the feasibility of collection, processing, and storage of these samples at the time of birth of infants with prenatal diagnosis of hypoplastic left heart syndrome. This study may be useful for the development of pre-clinical and clinical studies aimed at the long-term goal of repairing damaged heart muscle.

Condition Intervention
Hypoplastic Left Heart Syndrome (HLHS)
Other: Collection of umbilical cord blood

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science
Official Title: Umbilical Cord Blood Collection and Processing for Cardiac Regeneration in Hypoplastic Left Heart Syndrome Patients

Resource links provided by NLM:

Further study details as provided by Susana Cantero Peral, M.D., Ph.D., Mayo Clinic:

Primary Outcome Measures:
  • Percent of samples contaminated [ Time Frame: 14 days after collection ]
  • Percent of cells that are viable following post thaw analysis [ Time Frame: 5 years ]

Estimated Enrollment: 100
Study Start Date: May 2012
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Umbilical Cord Blood Collection Other: Collection of umbilical cord blood


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Any pregnant woman, regardless of age, with a prenatal diagnosis of HLHS
  • One or both parents willing to consent to the storage of umbilical cord blood for the specific purpose of regenerative research
  • Mother is willing to provide a blood sample for serology testing

Exclusion Criteria:

  • Individuals unwilling to participate
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01856049

Contact: Karen S Miller (507) 266-5510
Contact: Karen M Cavanaugh 507-538-8425

United States, Minnesota
Mayo Clinic Recruiting
Rochester, Minnesota, United States, 55905
Principal Investigator: Susana Cantero Peral, MD PhD         
Sponsors and Collaborators
Mayo Clinic
Principal Investigator: Susana Cantero Peral, M.D., Ph.D. Mayo Clinic
  More Information

Responsible Party: Susana Cantero Peral, M.D., Ph.D., PI, Mayo Clinic Identifier: NCT01856049     History of Changes
Other Study ID Numbers: 11-007176
Study First Received: May 14, 2013
Last Updated: August 5, 2016
Individual Participant Data  
Plan to Share IPD: No

Keywords provided by Susana Cantero Peral, M.D., Ph.D., Mayo Clinic:
Hypoplastic Left Heart Syndrome
UCB (umbilical cord blood)
Umbilical cord blood
Cord blood
Cardiac regeneration

Additional relevant MeSH terms:
Hypoplastic Left Heart Syndrome
Pathologic Processes
Heart Defects, Congenital
Cardiovascular Abnormalities
Cardiovascular Diseases
Heart Diseases
Congenital Abnormalities processed this record on May 25, 2017